N
NLS Pharma
Treatments for attention deficit hyperactivity disorder and other neurological disorders
About NLS Pharma
NLS Pharmaceutics is a biopharmaceutical company focused on designing affordable, safe, and effective drugs to safeguard and empower the brain throughout all stages of life. The company aims to improve quality of life and longevity by creating new approaches to treat mental and behavioral disorders, as well as enhancing cognitive function in healthy individuals. NLS Pharmaceutics operates in the healthcare and pharmaceutical market, serving patients with mental health needs and cognitive enhancement desires. The business model revolves around research and development of novel therapeutics, which are then brought to market through clinical trials and regulatory approvals. Revenue is generated through the sale of these drugs, partnerships, and licensing agreements.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Founded
- 2015
- Headquarters
- Zurich, Switzerland
- Listing
- IPO 2021
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later1 investor entered at this stage
Kadimastem
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about NLS Pharma on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See NLS Pharma on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.